Stock Market & Financial News
Stanford Study: Polymarket's Bitcoin Bets Were Rigged in the Final 10 Seconds
A small group of traders extracted $8.2 million from Polymarket's five-minute bitcoin contracts by pushing the spot price on Binance just before settlement, researchers from Stanford University and Singapore Management University found.
BlackRock: Don't Miss Out On This Dividend Growth Star
BlackRock remains on track to become a Dividend Aristocrat in 2034. The asset management giant crushed the analyst consensus for revenue and adjusted diluted EPS in Q2 2026. Boasting a sky-high interest coverage ratio, BlackRock is a financial fortress.
BLK The most popular bitcoin call option has slipped by $10,000
Bitcoin's BTC$64,174.67 booming options market has undergone a notable shift in positioning that could slow the largest cryptocurrency's ascent above $70,000.
Stable leads blockchains in 30-day TVL growth, Monad hits $621M after Aave deployment
Emerging blockchains like Stable and Monad highlight the shifting dynamics in DeFi, challenging established players and attracting new capital. Stable leads blockchains in 30-day TVL growth, Monad hits $621M after Aave deployment.
AMD stock sinks again despite bullish calls: what is spooking investors?
Advanced Micro Devices stock (NASDAQ: AMD) was heading for a second straight decline on Thursday despite bullish Wall Street research. AMD fell about 3.2% to $513 in premarket trading after dropping 3.5% on Wednesday, putting the stock on course for a two-session fall of about 6%.
AMD 
Jeff Booth, Lyn Alden-backed ORANGE JUICE raises $40 million to launch permanent capital firm with bitcoin treasury strategy
ORANGE JUICE raised $40 million to acquire businesses, pursue a bitcoin treasury strategy, and implement a permanent capital ownership model.
UnitedHealth stock jumps 6% after earnings beat, raised 2026 profit forecast
UnitedHealth Group raised its full-year profit outlook on Thursday after reporting second-quarter earnings that comfortably exceeded Wall Street expectations, signalling that the health insurer's turnaround efforts are beginning to gain traction even as elevated medical costs continue to weigh on the broader industry. Shares of the company rose more than 6% in premarket trading after the largest private health insurer in the United States posted stronger-than-expected earnings, improved profitability, and a lower medical cost ratio.
UNH 
Newmont: The Permits That Set The Stage For A Re-Rating
Newmont (NEM) is undervalued, trading at 0.82x NAV, with a Buy rating and $117 price target. Red Chris Block Cave permits unlock a major copper-gold resource, not yet reflected in NEM's share price. Upcoming project completions and Red Chris FID are expected to drive a production rebound and consensus estimate upgrades.
NEM 
Eli Lilly to Buy AtaiBeckley for Initial $2.8 Billion
Eli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion, continuing the drugmaker's recent buying spree.
ATAI 
Citi starts Hikma at 'buy' with strategy reset offering compelling entry point
Citi has initiated coverage of Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) with a 'buy' rating and a £17 price target, arguing the generic drugmaker's current valuation offers a compelling entry point. The 12-month target, based on a sum-of-the-parts valuation, implies a share price return of around 14%.
HKMPF 
Is First Trust Financials AlphaDEX ETF (FXO) a Strong ETF Right Now?
A smart beta exchange traded fund, the First Trust Financials AlphaDEX ETF (FXO) debuted on 05/08/2007, and offers broad exposure to the Financials ETFs category of the market.
FXO 
Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?
The WisdomTree International High Dividend ETF (DTH) made its debut on 06/16/2006, and is a smart beta exchange traded fund that provides broad exposure to the Broad Developed World ETFs category of the market.
DTH 
Is WisdomTree U.S. Multifactor ETF (USMF) a Strong ETF Right Now?
Launched on 06/29/2017, the WisdomTree U.S. Multifactor ETF (USMF) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Blend category of the market.
USMF 
Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now?
A smart beta exchange traded fund, the State Street SPDR S&P Retail ETF (XRT) debuted on 06/19/2006, and offers broad exposure to the Consumer Discretionary ETFs category of the market.
XRT 
Is WisdomTree U.S. Total Dividend ETF (DTD) a Strong ETF Right Now?
A smart beta exchange traded fund, the WisdomTree U.S. Total Dividend ETF (DTD) debuted on 06/16/2006, and offers broad exposure to the Style Box - Large Cap Value category of the market.
DTD 
BlackRock CEO Larry Fink expresses bullish outlook on bitcoin's stability
Fink's bullish stance on Bitcoin's stability may drive institutional adoption, reshaping crypto's role in traditional finance markets. BlackRock CEO Larry Fink expresses bullish outlook on bitcoin's stability.
Xenon Pharmaceuticals: Azetukalner Has Shifted From Binary Science To Commercial Execution
Xenon Pharmaceuticals (XENE) is transitioning into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform and strong Phase 3 epilepsy data. XENE's lead candidate, azetukalner, showed robust efficacy in refractory focal onset seizures and is progressing toward a Q3 2026 NDA filing. The company has a cash runway through 2029, supporting ongoing Phase 3 trials in MDD, bipolar depression, and pain, and is building a commercial infrastructure.
XENE 
Tesla's Delivery Surprise Was Big—Earnings Need to Be Bigger
Tesla TodayTSLATesla$394.35 -1.83 (-0.46%) As of 07/15/2026 04:00 PM Eastern52-Week Range$297.82▼$498.83P/E Ratio361.79Price Target$408.07Add to WatchlistTesla Inc. NASDAQ: TSLA shares have been consolidating ahead of the company's July 22 Q2 earnings report, with the stock's recent range continuing to narrow. That kind of price-action tightening is often a sign that the market is firmly in wait-and-see mode.
TSLA 
BlackRock Earnings: Market Dominance, Strong Inflows, And An Extreme Tail Risk
BlackRock, the world's largest asset manager, reported stellar results for the second quarter of 2026 yesterday. In this update, I'll analyze how BlackRock maintains an exceptional 40% operating margin while relentlessly lowering fees to starve out active management competitors. I'll explain a lesser-known revenue stream that grew 40% year-over-year and is increasingly contributing to offset the industry-wide decline in asset management fee rates.
BLK 
Microsoft: The Inflection Point May Finally Be Here
Microsoft (MSFT) trades at a rare discount, down 30% from its high, despite robust ≈17% EPS growth and sector-wide SaaS weakness. I see the market mispricing MSFT's AI integration; Office 365 remains entrenched while Copilot and Claude enhance, not disrupt, its software stack. Azure's 40% YoY growth is capacity-constrained, but management expects these limits to resolve by end-FY26, potentially accelerating growth into FY27.
MSFT 
Taiwan Semiconductor Manufacturing Company Limited (TSM) Q2 2026 Earnings Call Transcript
Taiwan Semiconductor Manufacturing Company Limited (TSM) Q2 2026 Earnings Call Transcript
TSM 
Fiskars Oyj Abp (FKRAF) Q2 2026 Earnings Call Transcript
Fiskars Oyj Abp (FKRAF) Q2 2026 Earnings Call Transcript
FKRAF 
Mips AB (publ) (MPZAY) Q2 2026 Earnings Call Transcript
Mips AB (publ) (MPZAY) Q2 2026 Earnings Call Transcript
MPZAY 
Nvidia unveils new AI model and expands Japan's physical AI ecosystem
Nvidia introduced its new AI model Cosmos 3 Edge. The company plans to expand physical AI ecosystem in Japan with local partners.
NVDA 
IYRI: Near-Term Risks Loom But The 11% Tax-Efficient Yield Stands Out
IYRI offers an 11% yield and tax-efficient distributions, appealing to income-focused investors seeking diversification and stable income. The covered call strategy caps upside potential, causing IYRI to lag in strong REIT rallies but ensures steady distributions even in flat markets. IYRI may underperform broader markets and REIT peers if rates rise or REITs rally, but excels in delivering reliable, tax-advantaged income.
IYRI 
Teradyne Is Expensive At First Glance But Attractive On Growth
I rate Teradyne a buy with a $484 price target, implying 43% upside from the current level of $339. TER's earnings model is being rebuilt around AI, benefiting from increased chip complexity and broader testing requirements across the AI supply chain. I estimate AI compute, photonics, robotics, and a recovery in mobile, automotive, and industrial testing can add approximately $5.11 in incremental EPS.
TER 
Alm. Brand A/S (ABDBY) Q2 2026 Earnings Call Transcript
Alm. Brand A/S (ABDBY) Q2 2026 Earnings Call Transcript
ABDBY 
How Current Refining Margins Are Driving an Edge for MPC (Revised)
Marathon Petroleum is leveraging strong refining margins, domestic crude sourcing and strategic upgrades to strengthen profitability as fuel markets stay tight.
MPC 
Warren Buffett Says He Now Likes “Four or Five” Businesses Berkshire Owns More than Alphabet. What Are They?
Warren Buffett rarely offers reservations about a $2 trillion tech giant. That's why his commentary on CNBC on July 15, 2026 caught our attention.
GOOG 
B&M divides City analysts as hopes of a turnaround face fresh scrutiny
B&M European Value Retail SA (LSE:BME) continues to split City opinion, with its first-quarter trading update sending Deutsche Bank to upgrade the discount retailer on signs that profit margins are stabilising, while Panmure Liberum abandoned its long-standing bullish stance. The contrasting reactions underline the uncertainty surrounding new chief executive Tjeerd Jegen's efforts to revive growth after several disappointing quarters.
CHCO 
